Dr. Delluc is the nominated principal investigator of two CIHR-funded international randomized controlled trials: SOME2, evaluating PET/CT cancer screening after unprovoked VTE, and SAVER, testing statins for secondary prevention of VTE. He also serves as co-principal investigator on the AIRPORT-MPN trial and co-investigator on RADIANT. He is an active mentor, supervising numerous trainees across disciplines and contributing to research capacity-building within the Thrombosis Program and OHRI.